News From Industry Sources
Celebrex Approved to Treat Juvenile Rheumatoid Arthritis
December 29, 2006
The U.S. Food and Drug Administration (FDA) approved Celebrex (celecoxib) for a new use - the relief of the signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) in patients two years of age and older. This approval follows the November 29 meeting of FDA's Arthritis Advisory Committee, in which the committee voted 15 to 1 in favor of approval of this product. Story
UVic Startup receives FDA Clearance
December 29, 2006
A new medical device created by a UVic spin-off company—which enhances the ability of physicians to measure, monitor and track patients’ pain—has been approved by the U.S. Food and Drug Administration (FDA) for sale in that country. Story
Nuvo Receives Approvable Letter from U.S. FDA for Pennsaid
December 29, 2006
Nuvo Research Inc. today announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Pennsaid® (1.5% w/w diclofenac sodium solution), a topical non-steroidal anti-inflammatory (NSAID) developed by Nuvo for use as a treatment of osteoarthritis (OA) of the knee. Story
EpiCept Licenses Patent for Bupivacaine in Back Pain to DURECT
December 26, 2006
EpiCept Corporation today announced it entered into a license agreement with DURECT Corporation pursuant to which it has granted DURECT the exclusive, worldwide rights to certain of EpiCept's intellectual property for a transdermal patch containing bupivacaine for the treatment of back pain. Story
Rofecoxib 12.5 Mg, Rofecoxib 25 Mg, and Celecoxib 200 Mg in the Treatment of Symptomatic Osteoarthritis: Results of Two Similarly Designed Studies*
December 23, 2006
Two similarly designed, multicenter, randomized, double- blind, placebo-controlled studies were undertaken to compare the efficacy of rofecoxib and celecoxib for the treatment of knee or hip OA over 6 weeks. Story
Tempur-Pedic Medical Introduces The Pro-HealthCore Bed by Tempur-Pedic(TM)
December 19, 2006
Tempur-Pedic Medical, a division of Tempur-Pedic North America Inc. introduces The Pro-HealthCore Bed by Tempur-Pedic(TM), specifically designed for health professionals to provide relief to those who suffer from pain. Story
Aptima and UMass Medical School Collaborate on Technology to Help Patients with Chronic Pain to Manage Their Health
December 20, 2006
Aptima, Inc. , a leader in human-centered engineering, and the University of Massachusetts Medical School are collaborating on the design and testing of a computer system that will help patients living with chronic pain, such as migraines, back conditions and osteoarthritis, to better manage their health treatments and interactions with health care providers. Story
HealthSonix' Research Study Shows Clinically Significant Pain Reduction With Osteoarthritis Patients
December 13, 2006
HealthSonix, Inc. today announced the completion of an AquaSonix Therapy "Guelph" clinical research study. The study was designed to measure the pain reduction and effectiveness of AquaSonix Therapy with people suffering with the pain of osteoarthritis, who were also actively involved in recreational aqua fitness classes. Story
|
